Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling

Fei Ting Hsu, Y. U Chang Liu, I. Tsang Chiang, Ren Shyan Liu, Hsin Ell Wang, Wuu Jyh Lin, Jeng Jong Hwang

Research output: Contribution to journalArticlepeer-review

47 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling'. Together they form a unique fingerprint.

Medicine & Life Sciences